[1]
2023. Remarkable and Prolonged Response to Melphalan and High-Dose Dexamethasone Combined Therapy of a Patient with Light-Chain Cardiac Amyloidosis. Biomedical Research and Therapy. 10, 11 (Nov. 2023), 6049–6056. DOI:https://doi.org/10.15419/bmrat.v10i11.846.